Our stories are reviewed by medical professionals to ensure you get the most accurate and useful information about your health and wellness. For more information, visit our medical review board. This ...
ATLANTA, June 24, 2024 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Epilepsia published findings from a comprehensive scoping review examining the efficacy of ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
TipRanks on MSN
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
ONO Pharmaceutical Co (($OPHLF)) announced an update on their ongoing clinical study. Study Overview: ONO Pharmaceutical Co. Ltd is conducting a ...
UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Unlike in adults, seizures, including status epilepticus (SE), may be the first and main ...
FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients two years of age and older 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback